Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Superinvestors holding IPSC, Q2 2026
No superinvestor reported holding IPSC in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of IPSC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−19.1%)
Q2 2021
1 superinvestor holding at quarter end